Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 18.77
+0.19 (1.02%)
Jul 31, 2026, 3:00 PM CST
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 8.56 billion as of July 31, 2026. Its market cap has decreased by -30.94% in one year.
Market Cap
8.56B
Enterprise Value
6.96B
Revenue
1.42B
Ranking
n/a
PE Ratio
78.42
Stock Price
18.77
ChartMarket Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 8.56B, an increase of 1,302.67%. That is a compound annual growth rate of 13.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 8.56B | -25.52% |
| Dec 31, 2025 | 11.49B | 30.57% |
| Dec 31, 2024 | 8.80B | -7.24% |
| Dec 29, 2023 | 9.49B | 19.17% |
| Dec 30, 2022 | 7.96B | -32.61% |
| Dec 31, 2021 | 11.81B | 28.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Vazyme Biotech | 9.01B |
| Jiangxi Fushine Pharmaceutical | 8.84B |
| Chengdu Olymvax Biopharmaceuticals | 8.75B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.40B |
| Liaoning Chengda Biotechnology | 8.22B |
| Sino Biological,Inc. | 8.21B |
| Chongqing Genrix Biopharmaceutical | 8.15B |
| Acrobiosystems | 8.09B |